Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 606-948-7 | CAS number: 2217-02-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- review article or handbook
- Title:
- Roles of human CYP2A6 and rat CYP2B1 in the oxidation of (+)-fenchol by liver microsomes
- Author:
- Miyazawa M
- Year:
- 2 006
- Bibliographic source:
- Xenobiotica, September 2007; 37(9), pp 943–953.
Materials and methods
- Objective of study:
- metabolism
- Principles of method if other than guideline:
- - Principle of test: Analysis of the metabolism of the test item in human liver microsomes
- Short description of test conditions: see description below
- Parameters analysed / observed: Identification of metabolites of the test item and kinetic analysis - GLP compliance:
- not specified
Test material
- Reference substance name:
- (1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol
- EC Number:
- 606-948-7
- Cas Number:
- 2217-02-9
- Molecular formula:
- C10H18O
- IUPAC Name:
- (1R,2R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-ol
Constituent 1
- Radiolabelling:
- no
Test animals
- Species:
- other: Human
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- Human liver microsomes were obtained from Gentest Corporation (Woburn, MA, USA) (HG23, HG03, HH18, HG88, HG74, HG06, HK37, HH13, HG64, HH47) and were stored at -80ºC.
Recombinant CYPs1A1, 1A2, 1B1, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, 3A4 expressed in microsomes of Trichoplusia ni cells infected with a baculovirus containing human P450 cDNA were obtained from Gentest Co. (Woburn, MA, USA).
Administration / exposure
- Route of administration:
- other: In vitro incubation with human liver microsomes
- Details on exposure:
- Biotransformation of (+)-fenchol by P450 enzymes were determined as follows:
Standard reaction mixtures contained human liver microsomes (0.1mgml-1) or recombinant P450 (10 pmol ml-1) with 100 µM (+)-fenchol in a final volume of 0.5 ml of 100mM potassium phosphate buffer (pH 7.4) containing an NADPH-generating system consisting of 0.5mM NADP+, 5mM glucose 6-phosphate, and 0.5 unit of glucose 6-phosphate dehydrogenase ml-1.
Incubations were carried out at 37ºC for 30 min and terminated by adding 1.5 ml of dichloromethane. Formation of oxidation increased linearly with incubation time up to 30 min. The mixtures were mixed vigorously and the extracts (organic layer) collected by centrifugation at 3000 rpm for 5 min.
The organic phase was transferred to an insert for analysis by gas chromatography-mass spectrometry
- Details on dosing and sampling:
- METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled: human liver microsomes
- Method type(s) for identification: GC-MS - Statistics:
- Kinetic parameters for (+)-fenchol metabolite formation by microsomes were estimated using a computer program (KaleidaGraph program from Synergy Software, Reading, PA, USA) designed for non-linear regression analysis of the hyperbolic Michaelis–Menten equation. Substrate concentrations used for the analysis of metabolism of (+)-fenchol were 5, 10, 50, 100, 200, 500 µM
Results and discussion
Main ADME results
- Type:
- metabolism
- Results:
- (+)-Fenchol was oxidized to fenchone by human liver microsomal P450 enzymes. CYP2A6 was identified as the major enzyme involved in the oxidation of (+)-fenchol by human liver microsomes.
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- Metabolite: Fenchone.
Kinetic analysis of (+)-fenchol oxidation catalysed by liver microsomes derived from human sample HG03 and recombinant CYP2A6 showed that the apparent Km values were 0.04 and 0.09mM, and the Vmax values were 0.29 and 6.96 nmol min-1 nmol-1 P450, respectively (See Table 1 below).
CYP2A6 is suggested to be the principal CYP enzyme in catalysing the oxidation in (+)-fenchol by human liver microsome.
Any other information on results incl. tables
Table 1. Kinetic analysis of the oxidation by human liver microsomes and recombinant P450 enzymes
expressed in Trichoplusia ni cells
Oxidation of (+)-Fenchol |
|||
|
Fenchone |
||
Enzyme source |
Km (1) |
Vmax (2) |
Vmax/km (3) |
HG03 |
0.04 |
0.29 |
7.25 |
CYP2A6 |
0.09 |
6.96 |
77.3 |
*Substrate concentrations used were 10, 50, 100, 200, 500, 750, 1000 µM.
(1) mM
(2) nmol/min/nmol P450
(3) nM-1 min-1.
Applicant's summary and conclusion
- Conclusions:
- The test item was oxidized to fenchone by human liver microsomal P450 enzymes, with CYP2A6 identified as the major enzyme involved.
- Executive summary:
The metabolism of the test item was studied by the analysis of incubations of in vitro-prepared human liver microsomes. Incubations were carried out at 37ºC for 30 min and contained human liver microsomes (0.1mgml-1) or recombinant P450 (10 pmol ml-1) with 100 mM test item in a final volume of 0.5 ml of 100mM potassium phosphate buffer (pH 7.4) containing an NADPH-generating system consisting
of 0.5mM NADP+, 5mM glucose 6-phosphate, and 0.5 unit of glucose 6-phosphate dehydrogenase ml-1. The biotransformation of the test item was investigated by gas chromatography-mass spectrometry (GC-MS). Under these conditions, the test item was found to be oxidized to fenchone, with CYP2A6 identified as the major enzyme involved.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
